King's College London

Funding Information: We gratefully acknowledge the continuing collaboration of people living with HIV, as well as clinicians, microbiologists, immunologists, public health practitioners, occupational health doctors, nurses and other colleagues who contribute to the surveillance of HIV in the UK. We also acknowledge the hard work of the PHE COVID-19 Epidemiology Cell in pulling together the death data. Funding Information: SEC, AEB, SN, MK, AKS, PK, JK, VD and SC have no conflicts of interest to declare. DB reports grants from ViiV Healthcare and Gilead Sciences outside the submitted work. LW reports speaker/advisory fees from Gilead Sciences, Viiv Healthcare, Merck Sharp & Dohme (MSD), Janssen‐Cilag, Cipla, Mylan and Theratechnologies and funding for clinical trials from Gilead Sciences and Janssen‐Cilag outside the submitted work. FAP reports grants and personal fees from Gilead Sciences, Viiv Healthcare, Janssen‐Cilag and MSD outside the submitted work. RFM reports personal fees from Gilead Sciences for conference attendance and non‐promotional talks outside the submitted work. CS reports funding from Gilead Sciences and Janssen‐Cilag for participation in advisory panels and for the preparation of educational materials outside the submitted work. DRC reports funding from Gilead Sciences and ViiV Healthcare for the preparation of educational materials and research grants outside the submitted work. RH reports educational consultancies from Gilead Sciences and ViiV Healthcare outside the submitted work. DA reports advisory fees from Gilead Sciences and Viiv Healthcare outside the submitted work. Publisher Copyright: © 2021 Crown copyright. HIV Medicine © 2021 British HIV Association. This article is published with the permission of the Controller of HMSO and the Queen's Printer for Scotland